BioSpace News Archive

Biotech Beach

AMJEVITA™ (ADALIMUMAB-ATTO), FIRST BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES

Amgen (NASDAQ:AMGN) today announced AMJEVITA™ (adalimumab-atto), a biosimilar to Humira ®* (adalimumab), is now available in the United States.

January 31, 2023
·
18 min read
Drug Development

Arugula Sciences announces FDA Approval to Proceed with Phase 1 Study of SIG002, a Perinatal-derived Secretome Product, for the Treatment of Big Toe Osteoarthritis (Hallux Rigidus)

Arugula Sciences announced today that it has received clearance from the FDA for its investigational new drug (IND) application for a Phase 1, open-label, dose-ranging clinical trial of SIG002, a perinatal-derived secretome product.

January 31, 2023
·
2 min read
BioMidwest

New Program Offers Critical Resources to the 34 million Americans Living with Lung Disease

More than 34 million Americans live with chronic obstructive pulmonary disease, asthma, pulmonary fibrosis, lung cancer and other lung diseases.

January 31, 2023
·
3 min read
Business

The Caris Precision Oncology Alliance Welcomes The UCI Health Chao Family Comprehensive Cancer Center

The UCI Health Chao Family Comprehensive Cancer Center joins Caris’ extensive network of leading cancer institutions committed to utilizing clinical data to advance patient care and outcomes.

January 31, 2023
·
5 min read
Business

ViewRay Announces Conference Call for Fourth Quarter 2022 Financial Results to be Held After Market on February 27, 2023

ViewRay, Inc. (NASDAQ: VRAY) announced today details relating to the release of fourth quarter 2022 financial results.

January 31, 2023
·
1 min read
Biotech Bay

NovaBay Pharmaceuticals to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that Justin Hall, CEO, will present a company overview at the virtual Sequire Biotechnology Conference on Thursday, February 2 at 2:30 p.m. Eastern time. To register for the event, visit the Sequire Biotechnology website.

January 31, 2023
·
4 min read
Business

Axsome Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 27Axsome to host conference call and webcast on Monday, Feb. 27, 2023, at 8:00 a.m. ET

Axsome Therapeutics, Inc. today announced that it will report its financial results for the fourth quarter and full year of 2022 on Monday, Feb. 27, 2023, before the opening of the U.S. financial markets.

January 31, 2023
·
4 min read
Business

Athira Pharma Announces Promotion of Kevin Church, Ph.D., to Chief Scientific Officer

Athira Pharma, Inc. today announced the promotion of Kevin Church, Ph.D., to Chief Scientific Officer.

January 31, 2023
·
4 min read
Business

PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023

PolyPid Ltd. today announced that it will report its fourth quarter and full year 2022 financial results and operational highlights before the open of the U.S. stock markets on Wednesday, February 8, 2023.

January 31, 2023
·
1 min read
BioMidwest

New Promega Chemistry Will Enable Forensic DNA Labs to Solve More Challenging Cold Cases, Sexual Assault Cases

New chemistry for DNA analysis will empower forensic laboratories to overcome common challenges including degraded and contaminated samples.

January 31, 2023
·
4 min read